Get the Stockscreener App
246.14
0.38%
-0.93
After Hours:
246.14
Overview
News
Price History
Option Chain
Financials
Why STE Down?
Discussions
Forecast
Stock Split
Dividend History
Steris Plc stock is traded at $246.14, with a volume of 447.13K.
It is down -0.38% in the last 24 hours and up +9.01% over the past month.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
See More
Previous Close:
$247.07
Open:
$246.74
24h Volume:
447.13K
Relative Volume:
0.71
Market Cap:
$24.21B
Revenue:
$5.46B
Net Income/Loss:
$614.64M
P/E Ratio:
39.70
EPS:
6.2
Net Cash Flow:
$778.00M
1W Performance:
+4.19%
1M Performance:
+9.01%
6M Performance:
+12.22%
1Y Performance:
+5.73%
1-Day Range:
$244.29
$246.85
1-Week Range:
$236.83
$248.06
52-Week Range:
$200.98
$252.79
Steris Plc Stock (STE) Company Profile
Name
Steris Plc
Sector
Industry
Phone
35312322000
Address
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
246.14 | 24.33B | 5.46B | 614.64M | 778.00M | 6.20 |
|
ABT
Abbott Laboratories
|
129.28 | 225.22B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.15 | 151.88B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.52 | 144.88B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.98 | 119.04B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.18 | 45.61B | 5.69B | 1.41B | 577.90M | 6.95 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-29-25 | Initiated | Jefferies | Hold |
| Oct-24-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| May-30-23 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-14-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-23-22 | Downgrade | Needham | Buy → Hold |
| Jul-14-22 | Initiated | Piper Sandler | Overweight |
| Apr-07-22 | Initiated | Wolfe Research | Outperform |
| May-26-21 | Upgrade | Needham | Hold → Buy |
| Feb-04-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-09-20 | Initiated | Needham | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-05-17 | Downgrade | Wellington Shields | Gradually Accumulate → Hold |
| May-03-17 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Nov-30-16 | Initiated | Goldman | Neutral |
| Jun-03-16 | Upgrade | Northcoast | Neutral → Buy |
| Jun-12-15 | Downgrade | Raymond James | Strong Buy → Outperform |
| May-07-13 | Downgrade | Griffin Securities | Buy → Hold |
| Feb-08-13 | Reiterated | Griffin Securities | Buy |
| Aug-03-12 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Feb-08-12 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-03-11 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-09-11 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-21-10 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-17-10 | Initiated | JMP Securities | Mkt Outperform |
| Apr-07-10 | Reiterated | CL King | Strong Buy |
| Mar-26-10 | Initiated | CL King | Strong Buy |
| Mar-03-10 | Initiated | Brean Murray | Hold |
View All
Steris Plc Stock (STE) Latest News
Will STERIS plc Recover After Recent DeclineJuly 2025 Snapshot & Weekly Sector Rotation Insights - classian.co.kr
STERIS plc (Ireland) (STE) Stock Forecasts - Yahoo Finance
Why STERIS (STE) Raised Its 2026 Revenue Guidance and What a CFO Transition Could Mean - simplywall.st
STERIS’s SWOT analysis: infection prevention leader faces tariff headwinds - Investing.com
Here's Why Steris (STE) is a Strong Growth Stock - sharewise.com
Steris Earnings: Robust Growth Across Segments; Full-Year Guidance Unchanged - Morningstar
STERIS plc (NYSE:STE) Q1 2026 Earnings Call Transcript - MSN
Understanding Steris (STE) Reliance on International Revenue - Yahoo Finance
Why STERIS (STE) Is Up 7.0% After Upbeat Outlook, Dividend Hike and CFO Transition - simplywall.st
KeyBanc’s Positive View on STERIS (STE) Driven by MedTech Momentum - Insider Monkey
STERIS plc: A Defensively Positioned MedTech Company with Strong Cash Generation - AInvest
Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target - MSN
Is STERIS plc impacted by rising ratesVerified 200% Stock Tips - mustnews.co.kr
STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View - MSN
STERIS plc Q1 Results: Analysts Forecast 5.7% Revenue Growth for 2026 - AInvest
STERIS (NYSE:STE) Upgraded to Strong-Buy at Wall Street Zen - Defense World
What risks could impact STERIS plc stock performanceIntraday Movement Recap and Chart Summary - Newser
Morgan Stanley Maintains Steris PLC(STE.US) With Buy Rating, Raises Target Price to $295 - 富途牛牛
Steris Plc shares rise 2.73% intraday after Morgan Stanley raised price target to $295. - AInvest
Morgan Stanley Adjusts Price Target on STERIS to $295 From $276, Maintains Overweight Rating - MarketScreener
Jefferies Adjusts Price Target on STERIS to $250 From $248, Maintains Hold Rating - MarketScreener
STERIS CFO to step down, successor named - MSN
STERIS Reports Strong Q1 Earnings and Revenue Growth - TipRanks
Steris Receives Hold Rating from Needham Analyst - AInvest
What makes STERIS plc stock price move sharplyDaily Stock Movement Forecast with Accuracy - Newser
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
Earnings call transcript: STERIS Q1 2025 sees earnings beat, stock rises 5.93% - Investing.com Nigeria
Earnings call transcript: STERIS Q1 2025 sees earnings beat, stock rises 5.93% By Investing.com - Investing.com South Africa
Steris anticipates 8–9% reported revenue growth in fiscal 2026 as currency tailwinds offset tariff headwinds - MSN
STERIS plc's Q1 2026: Navigating Tariff Turbulence and Life Sciences Growth Challenges - AInvest
STERIS Reports Q1 Earnings and Revenue Beat, Raises '26 Sales View - AInvest
STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year - simplywall.st
Zacks Research Brokers Reduce Earnings Estimates for STERIS - Defense World
Steris Tops Expectations And Lifts Its 2026 Outlook - Finimize
Steris PLC | 8-K: STERIS Announces Financial Results for Fiscal 2026 First Quarter - 富途牛牛
STERIS plc reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Steris (STE) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Steris Q1 adjusted profit beats estimates - MarketScreener
Steris (STE) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
STERIS CFO Michael Tokich to step down after 17 years By Investing.com - Investing.com Nigeria
Steris PLC Reports Q1 2026 Earnings: EPS of $1.79 Beats Estimates, Revenue Hits $1.4 Billion - GuruFocus
STERIS CFO Michael Tokich to step down after 17 years - Investing.com
STERIS Announces Chief Financial Officer Transition - The Globe and Mail
STERIS plc Announces CFO Transition as Michael J. Tokich to be Succeeded by Karen L. Burton - Quiver Quantitative
Earnings Flash (STE) STERIS plc Reports Q1 Revenue $1.40B, vs. FactSet Est of $1.36B - MarketScreener
Earnings Flash (STE) STERIS plc Posts Q1 Adjusted EPS $2.34 per Share, vs. FactSet Est of $2.26 - MarketScreener
STERIS Names New CFO as Company Veteran Drives $22 Billion Market Value Growth - Stock Titan
STERIS Announces Financial Results for Fiscal 2026 First Quarter - The Globe and Mail
Sterilization Services Market to Reach $8.77B by 2033 Amid HAI - openPR.com
STERIS plc (NYSE:STE) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Competitive Positioning of STERIS plc: Is It Leading or LaggingFree Entry and Exit Strategy Optimizer Tool - Newser
Steris Plc Stock (STE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):